Cargando…
Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies
Abstract Tumor lysis syndrome (TLS) is a potentially life-threatening emergency that can develop rapidly after the release of intracellular contents from lysed malignant cells. The advent of novel and targeted therapies that have improved tumor-killing efficacy has the potential to increase the risk...
Autores principales: | McBride, Ali, Trifilio, Steven, Baxter, Nadine, Gregory, Tara K., Howard, Scott C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188097/ https://www.ncbi.nlm.nih.gov/pubmed/30333933 |
Ejemplares similares
-
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
por: McBride, Ali, et al.
Publicado: (2012) -
Diagnosis and management of tumor lysis syndrome.
por: Puri, Isha, et al.
Publicado: (2020) -
Prevention and Management of Tumor Lysis Syndrome in Adults With Malignancy
por: Sarno, Jessica
Publicado: (2013) -
Spontaneous Tumor Lysis Syndrome
por: Wesemüller, Wiebke, et al.
Publicado: (2020) -
Spontaneous Tumor Lysis Syndrome as Presenting Sign of Metastatic Prostate Cancer
por: McGhee-Jez, Amy, et al.
Publicado: (2018)